The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients

The ZIPANGU study assessed the efficacy and safety of ranibizumab as a one loading dose + pro re nata (one + PRN) regimen with/without focal/grid laser among treatment-naïve patients suffering from macular edema (ME) following branch retinal vein occlusion (BRVO). ZIPANGU was a phase IV, prospective...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Rep
Main Authors: Murata, Toshinori, Kondo, Mineo, Inoue, Makoto, Nakao, Shintaro, Osaka, Rie, Shiragami, Chieko, Sogawa, Kenji, Mochizuki, Akikazu, Shiraga, Rumiko, Ohashi, Yohei, Kaneko, Takeumi, Chandrasekhar, Chikatapu, Tsujikawa, Akitaka, Kamei, Motohiro
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2021
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7804316/
https://ncbi.nlm.nih.gov/pubmed/33436683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79051-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים